Clinical Effectiveness of Telemedicine in Diabetes Mellitus: A Meta-Analysis of 42 Randomized Controlled Trials

Tchero, Huidi; Kangambega, P.; Briatte, Christine; Brunet-Houdard, Solenne; Retali, Gerald-Reparate; Rüsch, Emmanuel

doi:10.1089/tmj.2018.0128

Cited by 157 publications

(119 citation statements)

References 64 publications

Supporting

Mentioning

111

Contrasting

Unclassified

Order By: Relevance

“…[9][10][11][12] There is currently limited literature regarding the use of THCa in GDM patients, with most studies conducted in patients with type 1 and type 2 diabetes outside pregnancy. 13 Previous studies comparing THCa intervention to usual care in pregnant women with GDM reported similar glycemic control and maternal-fetal complications rates [14][15][16] in both groups, but in the THCa group, empowerment in terms of GDM management 14 as well as satisfaction with care were improved. 16 Furthermore, Pérez-Ferre et al demonstrated that THCa reduced unplanned medical visits by 62%, a decrease that was more important in insulin-treated patients (83%).…”

Section: Introductionmentioning

confidence: 85%

Demonstrated Cost-Effectiveness of a Telehomecare Program for Gestational Diabetes Mellitus Management

Lemelin

Paré

Bernard

et al. 2020

Diabetes Technology & Therapeutics

View full text Add to dashboard Cite

Background: Prevalence of gestational diabetes mellitus (GDM) has increased steadily in recent years. Pregnant women with GDM are at risk for obstetrical and neonatal complications and require close multidisciplinary follow-up, which implies a significant use of hospital resources. Methods: A prospective noninferiority and controlled clinical trial was designed. The telehomecare (THCa) initiative is a clinical remote patient management project in women with GDM. The main objective was to evaluate the cost-effectiveness of THCa by assessing the direct costs, including the related reduction in medical visits. Secondary outcomes were to evaluate the impact of THCa on diabetes control, GDM-related complications, and patient satisfaction. Results: A total of 161 women were assigned to either an intervention group provided with a THCa system for transmission and online analysis of capillary glucose data (n = 80) or a control group receiving usual care in the clinic (n = 81). A decrease in medical visits by 56% (P < 0.001) in the THCa group was observed. There was no difference between the two groups in diabetes control or maternal and fetal complications. However, results showed a 10-fold increase in nursing interventions in THCa group (mainly by phone calls and e-mails). Satisfaction with care was high. Direct cost analysis revealed savings of 16% in patients followed by THCa compared with the control group. Conclusion: THCa monitoring significantly decreases medical visits and direct costs in GDM women without compromising pregnancy outcomes, quality of care, or patient satisfaction. THCa was shown to be costeffective despite placing an additional burden on nursing time.

show abstract

Section: Introductionmentioning

confidence: 85%

Demonstrated Cost-Effectiveness of a Telehomecare Program for Gestational Diabetes Mellitus Management

Lemelin

Paré

Bernard

et al. 2020

Diabetes Technology & Therapeutics

View full text Add to dashboard Cite

show abstract

“…A meta-analysis of 42 randomized, controlled trials conducted by Tchero et al showed that telemedicine intervention is more effective in managing diabetes in elderly patients than ordinary care [ 39 ].…”

Section: Related Work and Discussionmentioning

confidence: 99%

What Features and Functions Are Desired in Telemedical Services Targeted at Polish Older Adults Delivered by Wearable Medical Devices?—Pre-COVID-19 Flashback

Kańtoch

2020

Sensors

View full text Add to dashboard Cite

The emerging wearable medical devices open up new opportunities for the provision of health services and promise to accelerate the development of novel telemedical services. The main objective of this study was to investigate the desirable features and applications of telemedical services for the Polish older adults delivered by wearable medical devices. The questionnaire study was conducted among 146 adult volunteers in two cohorts (C.1: <65 years vs. C.2: ≥65 years). The analysis was based on qualitative research and descriptive statistics. Comparisons were performed by Pearson’s chi-squared test. The questionnaire, which was divided into three parts (1-socio-demographic data, needs, and behaviors; 2-health status; 3-telemedicine service awareness and device concept study), consisted of 37 open, semi-open, or closed questions. Two cohorts were analyzed (C.1: n = 77; mean age = 32 vs. C.2: n = 69; mean age = 74). The performed survey showed that the majority of respondents were unaware of the telemedical services (56.8%). A total of 62.3% of C.1 and 34.8% of C.2 declared their understanding of telemedical services. The 10.3% of correct explanations regarding telemedical service were found among all study participants. The most desirable feature was the detection of life-threatening and health-threatening situations (65.2% vs. 66.2%). The findings suggest a lack of awareness of telemedical services and the opportunities offered by wearable telemedical devices.

show abstract

“…A 2019 meta-analysis published in the journal Telemedicine and e-Health, researchers from several university hospitals in France analyzed 42 randomized controlled trials investigating the use of telemedicine (8 studies used teleconsultation and 34 used devicebased telemonitoring) vs usual care in diabetes management [12]. Th ey examined data from a total of 6170 patients (mean ages, 13.3-71.0 years) from 12 studies focused on type 1 diabetes, 21 focused on type 2 diabetes, and 9 that included both patients with type 1 and type 2 diabetes.…”

Section: Role Of Telemedicine In Diabetesmentioning

confidence: 99%

How do we ensure safety for patients and clinicians while utilising Telemedicine in the field of Diabetes

Aurangabadkar¹

2020

RIJED

View full text Add to dashboard Cite

Telemedicine use has been at its highest for patients in recent times due to ongoing COVID 19 pandemics. Although avoidance of face to face consultations carries many advantages for both patients and clinicians, there are always concerns around safety and legal aspects. So, how do we assure that the way of using teleconsultation in the ield of diabetes is a mutually safe, effective, and sustainable option in the long term? This article lays out some important solutions addressing underlying apprehension and barriers in the use of telemedicine for diabetes. This is obviously truly relevant in the current scenario of COVID 19 where we anticipate continued use of telemedicine in near future.

show abstract

Clinical Effectiveness of Telemedicine in Diabetes Mellitus: A Meta-Analysis of 42 Randomized Controlled Trials

Abstract: Telemedicine interventions are more effective than usual care in managing diabetes, especially type 2 diabetes. Furthermore, older patients and a longer duration of intervention provide superior results.

Cited by 157 publications

References 64 publications

Demonstrated Cost-Effectiveness of a Telehomecare Program for Gestational Diabetes Mellitus Management

Demonstrated Cost-Effectiveness of a Telehomecare Program for Gestational Diabetes Mellitus Management

What Features and Functions Are Desired in Telemedical Services Targeted at Polish Older Adults Delivered by Wearable Medical Devices?—Pre-COVID-19 Flashback

How do we ensure safety for patients and clinicians while utilising Telemedicine in the field of Diabetes

Contact Info

Product

Resources

About